Paying cash on November 16, 2026, tirzepatide costs from $69 a month compounded (drug price) or $299 as Zepbound, and semaglutide from $59 a month compounded (drug price) or $149 as the Wegovy pill.
No insurance needed. Two programs to check.
Eden$99 a monthWeight loss warranty includedCheck price →
Collective$59 a month, drug priceLowest price on our chartCheck price →
Tirzepatide and semaglutide are two different medicines. Eli Lilly sells tirzepatide as Zepbound and Mounjaro, and Novo Nordisk sells semaglutide as Wegovy and Ozempic. Pharmacies also compound both, and that is where the lowest cash prices are. The FDA has not approved the compounded versions.
Tirzepatide vs Semaglutide, side by side
| Tirzepatide | Semaglutide |
|---|---|
| Brand names | |
| Zepbound for weight loss, Mounjaro for type 2 diabetes | Wegovy for weight loss, Ozempic for type 2 diabetes |
| Made by | |
| Eli Lilly | Novo Nordisk |
| Compounded, cash | |
| From $69 a month at Collective (drug price, plus a yearly membership), or $129 at Eden with no yearly membership | From $59 a month at Collective (drug price, plus a yearly membership), or $79 at CoreAge Rx with no yearly membership |
| Brand name for weight loss, cash | |
| Zepbound at LillyDirect: $299 at 2.5 mg, $399 at 5 mg and $449 to $699 at 7.5 mg and up | Wegovy at NovoCare: $349 a month for the pen and $399 for the 7.2 mg HD pen. The pill: $149 at 1.5 mg, $199 at 4 mg and $299 at 9 mg and 25 mg |
| Brand name for type 2 diabetes, cash | |
| Mounjaro at LillyDirect: $499 a month | Ozempic at NovoCare: $349 to $499 a month by dose |
| List price before insurance | |
| Zepbound $499 to $1,086.37 a fill. Mounjaro $1,112.16 a fill | Wegovy $1,349.02 a fill. Ozempic $1,027.51 a fill |
| Savings card, with commercial insurance | |
| Zepbound: as low as $25 for a 1, 2 or 3-month Rx (annual max $1,300), until December 31, 2026 | Wegovy: as low as $25/mo (max $100/mo off) |
| Medicare GLP-1 Bridge | |
| $50 a month, Zepbound KwikPen only | $50 a month |
| How often | |
| Once a week, by injection | Once a week by injection. The Wegovy pill is once a day |
| Weight loss in SURMOUNT-5, the head-to-head trial | |
| 20.2 percent of body weight on average at 72 weeks | 13.7 percent of body weight on average at 72 weeks |
Cash prices are the sellers' own, checked November 16, 2026. You need a prescription for every row.
Compounded tirzepatide vs compounded semaglutide
Compounded tirzepatide costs from $69 a month at Collective (drug price, plus a yearly membership), or $129 at Eden with no yearly membership. Compounded semaglutide costs from $59 a month at Collective (drug price, plus a yearly membership), or $79 at CoreAge Rx with no yearly membership. At the lowest price on each, tirzepatide costs $10 more a month.
A licensed pharmacy makes a compounded drug against a prescription. The FDA has not approved it and does not review it before it is sold. Every program's price is on tirzepatide cost and semaglutide cost.
Brand-name cost without insurance
For weight loss, LillyDirect sells Zepbound at $299 at 2.5 mg, $399 at 5 mg and $449 to $699 at 7.5 mg and up. NovoCare sells Wegovy at $349 a month for the pen and $399 for the 7.2 mg HD pen, and the Wegovy pill at $149 at 1.5 mg, $199 at 4 mg and $299 at 9 mg and 25 mg.
For type 2 diabetes, LillyDirect sells Mounjaro at $499 a month and NovoCare sells Ozempic at $349 to $499 a month by dose.
Those are the makers' cash prices. Their list prices, before insurance or any discount, are $499 to $1,086.37 a fill for Zepbound and $1,112.16 a fill for Mounjaro, against $1,349.02 a fill for Wegovy and $1,027.51 a fill for Ozempic. Each brand by dose: Zepbound cost, Wegovy cost, Mounjaro cost and Ozempic cost.
Which one took off more weight
One trial has put the two against each other for weight loss. SURMOUNT-5 gave 751 adults with obesity and no type 2 diabetes the highest dose of tirzepatide or semaglutide they could tolerate, once a week for 72 weeks. Tirzepatide took off 20.2 percent of body weight on average and semaglutide 13.7 percent. Eli Lilly paid for the trial, and everyone in it knew which drug they were on.
The doses were 10 mg or 15 mg of tirzepatide and 1.7 mg or 2.4 mg of semaglutide. We set out the design and its limits in semaglutide vs tirzepatide, the head-to-head results.
Dosing schedule
Both are weekly injections that start low and step up. The Zepbound label starts at 2.5 mg for 4 weeks and moves to 5 mg after 4 weeks, then 2.5 mg increments after at least 4 weeks on the current dose. It names 5 mg, 10 mg or 15 mg as the doses to stay on.
The Wegovy label starts at 0.25 mg, weeks 1 to 4, then 0.5 mg weeks 5 to 8, 1 mg weeks 9 to 12, 1.7 mg weeks 13 to 16. From week 17 the dose is 1.7 mg or 2.4 mg, and the label allows up to 7.2 mg weekly. The steps by week: Zepbound dosing and Wegovy dosing.
What savings cards and Medicare do for each
The makers' savings cards need commercial insurance that covers the drug. Zepbound's card terms read as low as $25 for a 1, 2 or 3-month Rx (annual max $1,300), until December 31, 2026. Wegovy's read as low as $25/mo (max $100/mo off). Neither works with Medicare or Medicaid.
Medicare's GLP-1 Bridge charges $50 a month to Part D members who qualify, from July 1, 2026 to December 31, 2027, and its list covers Wegovy and the Zepbound KwikPen. Ozempic and Mounjaro are not on that list.
People with type 2 diabetes or sleep apnea are outside the Bridge. Medicare says their Part D plan might cover the drug instead.
Questions people ask
Is tirzepatide more expensive than semaglutide?
Which works better for weight loss, tirzepatide or semaglutide?
Are tirzepatide and semaglutide the same thing?
Does Medicare cover tirzepatide or semaglutide?
Compare other GLP-1 medications
- Ozempic vs Wegovy
- Ozempic vs Mounjaro
- Zepbound vs Ozempic
- Foundayo vs the Wegovy pill
- Mounjaro vs Zepbound
- Wegovy vs Zepbound cost
- Is there a generic GLP-1?
- Every GLP-1 medication side by side
- Tirzepatide cost and Semaglutide cost
Sources
Evidence checked November 15, 2026
Every figure above is taken from the document beside it, the FDA label or the trial that produced it, so you can read the source instead of trusting us. How we check sources.
8 documents
- Zepbound's approved uses, its dose steps and how tirzepatide worksFDA prescribing information for Zepbound (DailyMed, revised August 2026)
- Wegovy's approved uses, its dose steps and how semaglutide worksFDA prescribing information for Wegovy, injection and tablets (DailyMed, revised June 2026)
- SURMOUNT-5: tirzepatide against semaglutide in 751 adults with obesity and no type 2 diabetes, 20.2 percent against 13.7 percent of body weight at 72 weeksAronne LJ et al. N Engl J Med 2025;393(1):26-36 (PubMed 40353578)
- The FDA has not approved compounded drugs and does not review them before they are soldFDA's concerns with unapproved GLP-1 drugs used for weight loss (FDA)
- Which GLP-1 drugs the Medicare GLP-1 Bridge covers, who qualifies and who is outside itWeight loss drugs (Medicare.gov)
- The Bridge's $50 copay and its dates, July 1, 2026 to December 31, 2027Medicare GLP-1 Bridge (CMS)
- Mounjaro's list price for one fill, before insurance or discountsMounjaro cost information (Eli Lilly)
- Zepbound's list price range for one fill, before insurance or discountsZepbound cost information (Eli Lilly)
Prices from the programs' own pages, LillyDirect, NovoCare and the makers' list price and savings card pages, checked November 16. How we check prices.